These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35954640)

  • 1. Changes in Racial/Ethnic Disparities in Opioid-Related Outcomes in Urban Areas during the COVID-19 Pandemic: A Rapid Review of the Literature.
    Moran KM; Mullachery PH; Lankenau S; Bilal U
    Int J Environ Res Public Health; 2022 Jul; 19(15):. PubMed ID: 35954640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A qualitative analysis of barriers to opioid agonist treatment for racial/ethnic minoritized populations.
    Husain JM; Cromartie D; Fitzelle-Jones E; Brochier A; Borba CPC; Montalvo C
    J Subst Abuse Treat; 2023 Jan; 144():108918. PubMed ID: 36403456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Structural Barriers and Racial Group Disparities of COVID-19 Mortality With Spatial Analysis.
    Lin Q; Paykin S; Halpern D; Martinez-Cardoso A; Kolak M
    JAMA Netw Open; 2022 Mar; 5(3):e220984. PubMed ID: 35244703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19.
    Rosales R; Janssen T; Yermash J; Yap KR; Ball EL; Hartzler B; Garner BR; Becker SJ
    J Subst Abuse Treat; 2022 Jan; 132():108648. PubMed ID: 34742607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial/ethnic disparities in the availability of hospital based opioid use disorder treatment.
    Chang JE; Franz B; Cronin CE; Lindenfeld Z; Lai AY; Pagán JA
    J Subst Abuse Treat; 2022 Jul; 138():108719. PubMed ID: 35125254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of Social and Structural COVID-19 Disparities by Sexual Orientation, Gender Identity, and Race/Ethnicity in an Urban Environment.
    Ruprecht MM; Wang X; Johnson AK; Xu J; Felt D; Ihenacho S; Stonehouse P; Curry CW; DeBroux C; Costa D; Phillips Ii G
    J Urban Health; 2021 Feb; 98(1):27-40. PubMed ID: 33259027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review.
    Alexander K; Pogorzelska-Maziarz M; Gerolamo A; Hassen N; Kelly EL; Rising KL
    Subst Abuse Treat Prev Policy; 2021 Aug; 16(1):60. PubMed ID: 34372900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural racism and COVID-19 response: higher risk of exposure drives disparate COVID-19 deaths among Black and Hispanic/Latinx residents of Illinois, USA.
    Holden TM; Simon MA; Arnold DT; Halloway V; Gerardin J
    BMC Public Health; 2022 Feb; 22(1):312. PubMed ID: 35168585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Devastating Economic Impact of COVID-19 on Older Black and Latinx Adults: Implications for Health and Well-Being.
    Garcia MA; Thierry AD; Pendergrast CB
    J Gerontol B Psychol Sci Soc Sci; 2022 Aug; 77(8):1501-1507. PubMed ID: 34850887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential impacts of COVID-19 across racial-ethnic identities in persons with opioid use disorder.
    Mistler CB; Sullivan MC; Copenhaver MM; Meyer JP; Roth AM; Shenoi SV; Edelman EJ; Wickersham JA; Shrestha R
    J Subst Abuse Treat; 2021 Oct; 129():108387. PubMed ID: 34080555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "How will I get my next week's script?" Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic.
    Krawczyk N; Bunting AM; Frank D; Arshonsky J; Gu Y; Friedman SR; Bragg MA
    Int J Drug Policy; 2021 Jun; 92():103140. PubMed ID: 33558165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of State and Federal Health Policies for Opioid Use Disorder Treatment During the COVID-19 Pandemic and Beyond.
    Pessar SC; Boustead A; Ge Y; Smart R; Pacula RL
    JAMA Health Forum; 2021 Nov; 2(11):e213833. PubMed ID: 35647581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and Ethnic Disparities in Postpartum Care in the Greater Boston Area During the COVID-19 Pandemic.
    Mi T; Hung P; Li X; McGregor A; He J; Zhou J
    JAMA Netw Open; 2022 Jun; 5(6):e2216355. PubMed ID: 35737390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and Ethnic Disparities in Hospitalization Outcomes Among Medicare Beneficiaries During the COVID-19 Pandemic.
    Song Z; Zhang X; Patterson LJ; Barnes CL; Haas DA
    JAMA Health Forum; 2021 Dec; 2(12):e214223. PubMed ID: 35977303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the COVID-19 Pandemic on Functions of Nursing Professionals in the Care of Opioid Use Disorder: Systematic Review.
    Brown KG; Chen CY; Dong D; Lake KJ; Butelman ER
    J Addict Nurs; 2024 Apr-Jun 01; 35(2):107-113. PubMed ID: 38830000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Pre-operative Opioid Use on Racial Disparities in Adverse Outcomes Post Total Knee and Hip Arthroplasty.
    Mohammed H; Parks M; Ibrahim S; Magnus M; Ma Y
    J Racial Ethn Health Disparities; 2023 Dec; 10(6):3051-3061. PubMed ID: 36478270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial disparities in Coronavirus Disease 2019 (COVID-19) outcomes.
    Aleligne YK; Appiah D; Ebong IA
    Curr Opin Cardiol; 2021 May; 36(3):360-366. PubMed ID: 33657019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health disparities in past influenza pandemics: A scoping review of the literature.
    D'Adamo A; Schnake-Mahl A; Mullachery PH; Lazo M; Diez Roux AV; Bilal U
    SSM Popul Health; 2023 Mar; 21():101314. PubMed ID: 36514788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The trajectory of racial/ethnic disparities in the use of cancer screening before and during the COVID-19 pandemic: A large U.S. academic center analysis.
    Marcondes FO; Cheng D; Warner ET; Kamran SC; Haas JS
    Prev Med; 2021 Oct; 151():106640. PubMed ID: 34217419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What can we learn from COVID-19 to improve opioid treatment? Expert providers respond.
    Harris LM; Marsh JC; Khachikian T; Serrett V; Kong Y; Guerrero EG
    J Subst Use Addict Treat; 2023 Nov; 154():209157. PubMed ID: 37652210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.